<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(1)</volume><submitter>Banerjee R</submitter><journal>Blood cancer journal</journal><pagination>162</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10625982</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians.</pubmed_title><pmcid>PMC10625982</pmcid><pubmed_authors>Banerjee R</pubmed_authors><pubmed_authors>Kaur G</pubmed_authors><pubmed_authors>Wang B</pubmed_authors><pubmed_authors>Mehra N</pubmed_authors><pubmed_authors>Rajkumar SV</pubmed_authors><pubmed_authors>McCaughan G</pubmed_authors><pubmed_authors>Cowan AJ</pubmed_authors><pubmed_authors>Anderson LD</pubmed_authors></additional><is_claimable>false</is_claimable><name>Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians.</name><description/><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2025-04-21T17:24:15.59Z</modification><creation>2025-02-19T01:52:42.978Z</creation></dates><accession>S-EPMC10625982</accession><cross_references><pubmed>37926718</pubmed><doi>10.1038/s41408-023-00937-0</doi></cross_references></HashMap>